Properties (50)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
medication
|
| gptkbp:approves |
gptkb:FDA
|
| gptkbp:availableIn |
tablet
injectable solution |
| gptkbp:brand |
gptkb:Protonix
|
| gptkbp:chemicalFormula |
C16H15F2N3O4S
|
| gptkbp:clinicalTrials |
Phase III
|
| gptkbp:commonName |
20 mg once daily
40 mg once daily |
| gptkbp:contraindication |
liver enzyme elevation
severe liver disease vitamin B12 deficiency gastrointestinal infections hypomagnesemia hypersensitivity to pantoprazole |
| gptkbp:drugInterdiction |
proton pump inhibitors
|
| gptkbp:formulation |
powder for injection
enteric-coated tablet delayed-release tablet |
| gptkbp:gestationPeriod |
B
|
| gptkbp:hasAlumni |
kidney disease
dementia stomach cancer |
| gptkbp:hasFilm |
kidney disease
bone fractures clostridium difficile infection |
| https://www.w3.org/2000/01/rdf-schema#label |
pantoprazole
|
| gptkbp:interactsWith |
warfarin
methotrexate clopidogrel |
| gptkbp:isATypeOf |
102625-71-8
|
| gptkbp:lastProduced |
2000
|
| gptkbp:marketedAs |
Takeda_Pharmaceuticals
|
| gptkbp:numberOfStudents |
1 hour
|
| gptkbp:nutritionalValue |
liver
|
| gptkbp:operates_in |
A02BC02
|
| gptkbp:route |
oral
intravenous |
| gptkbp:sells |
Pantoloc
Tecta |
| gptkbp:sideEffect |
headache
nausea abdominal pain diarrhea |
| gptkbp:storage |
room temperature
|
| gptkbp:triggerType |
proton pump inhibitor
|
| gptkbp:usedFor |
treatment of gastroesophageal reflux disease (GERD)
treatment_of_Zollinger-Ellison_syndrome |
| gptkbp:waterManagement |
urine
|
| gptkbp:year |
2000
|